LJPC
La Jolla Pharmaceutical Company
LJPC
LJPC
Delisted
LJPC was delisted on the 19th of August, 2022.
45 hedge funds and large institutions have $70.4M invested in La Jolla Pharmaceutical Company in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 23 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
74% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 23
Holders
45
Holding in Top 10
3
Calls
$102K
Puts
–
Top Buyers
| 1 | +$394K | |
| 2 | +$184K | |
| 3 | +$147K | |
| 4 |
RWM
Ritholtz Wealth Management
New York
|
+$65.5K |
| 5 |
D.E. Shaw & Co
New York
|
+$49.1K |
Top Sellers
| 1 | -$536K | |
| 2 | -$353K | |
| 3 | -$264K | |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
-$134K |
| 5 |
Two Sigma Advisers
New York
|
-$111K |